Evidence map›Paper›PMID 39596280›Full record

ArticleInternational journal of molecular sciences2024

Interleukin-6 Modulates the Expression and Function of HCN Channels: A Link Between Inflammation and Atrial Electrogenesis.

Valentina Spinelli, Annunziatina Laurino, Valentina Balducci, Manuela Gencarelli, Jessica Ruzzolini, Chiara Nediani, Giulia Elena Mandoli, Matteo Cameli, Leonardo Sacconi, Laura Sartiani and 1 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Review
  5. Immunomodulatory Potential of Kaempferol Isolated fromInternational journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Valentina SpinelliDepartment of Neuroscience, Innovative Treatment, Drug Research and Child Health, University of Firenze, 50139 Firenze, Italy.ORCID 0000-0001-6083-6983
Annunziatina LaurinoDepartment of Neuroscience, Innovative Treatment, Drug Research and Child Health, University of Firenze, 50139 Firenze, Italy.
Valentina BalducciDepartment of Neuroscience, Innovative Treatment, Drug Research and Child Health, University of Firenze, 50139 Firenze, Italy.ORCID 0000-0001-9158-8556
Manuela GencarelliDepartment of Neuroscience, Innovative Treatment, Drug Research and Child Health, University of Firenze, 50139 Firenze, Italy.
Jessica RuzzoliniDepartment of Neuroscience, Innovative Treatment, Drug Research and Child Health, University of Firenze, 50139 Firenze, Italy.
Chiara NedianiDepartment of Experimental and Clinical Biomedical Sciences, University of Firenze, 50139 Firenze, Italy.ORCID 0000-0003-3190-3539
Giulia Elena MandoliDepartment of Medical Biotechnologies, Division of Cardiology, University of Siena, 53100 Siena, Italy.
Matteo CameliDepartment of Medical Biotechnologies, Division of Cardiology, University of Siena, 53100 Siena, Italy.ORCID 0000-0003-3872-8964
Leonardo SacconiInstitute of Clinical Physiology, National Research Council, 50139 Florence, Italy.ORCID 0000-0002-9320-5085
Laura SartianiDepartment of Neuroscience, Innovative Treatment, Drug Research and Child Health, University of Firenze, 50139 Firenze, Italy.ORCID 0000-0002-4208-0913
Elisabetta CerbaiDepartment of Neuroscience, Innovative Treatment, Drug Research and Child Health, University of Firenze, 50139 Firenze, Italy.ORCID 0000-0001-7839-1361

Funding

Fondazione Cassa di Risparmio di Firenze BRAINItalian Minister of University and Research 2022XJ7TECItalian Minister of University and Research FISR2020IP_00985Regione Toscana BANDO RICERCA COVID 19 TOSCANA, DD n. 7731/2020, PRECARVID
6 · The paper itself

Abstract

Inflammatory cytokines, including interleukin 6 (IL6), are associated with ion channel remodeling and enhance the propensity to alterations in cardiac rhythm generation and propagation, in which the hyperpolarization-activated cyclic nucleotide-gated (HCN) channels play a crucial role. Hence, we investigated the consequences of exposure to IL6 on HCN channels in cell models and human atrial biopsies. In murine atrial HL1 cells and in cardiomyocytes derived from human induced pluripotent stem cells (hiPS-CMs), IL6 elicited STAT3 phosphorylation, a receptor-mediated downstream signaling. Downregulation of HCN1,2,4 by IL6 was observed after 24-48 h; in hiPS-CMs, this effect was reverted by 24 h of application of tocilizumab, a human IL6 receptor antagonist. In parallel, hiPS-CM action potentials (APs) showed a reduced spontaneous frequency. Moreover, we assessed IL6 and HCN expression in dilated left atrial samples from patients with mitral valve disease, an AF-prone condition. IL6 levels were increased in dilated atria compared to controls and positively correlated with echocardiographic atrial dimensions. Interestingly, the highest IL6 transcript levels and the lowest HCN4 and HCN2 expression were in these samples. In conclusion, our data uncovered a novel link between IL6 and cardiac HCN channels, potentially contributing to atrial electrical disturbances and a higher risk of dysrhythmias in conditions with elevated IL6 levels.

Indexed as

Heart AtriaHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsInflammationInterleukin-6Myocytes, CardiacAction PotentialsAnimalsCell LineFemaleHumansInduced Pluripotent Stem CellsMaleMiceMiddle AgedSTAT3 Transcription FactorHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsInterleukin-6STAT3 Transcription Factoratrial electrogenesiscardiomyocytesHCN channelsIL6inflammation

Identifiers

PMID39596280
PMCPMC11594737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.